Bayer is a Life Science company with a more than 150-year history and core competencies in the areas of health care and agriculture.

At Pharmaceuticals, our largest segment in terms of sales, we focus on researching, developing and marketing specialty-focused innovative medicines that provide significant clinical benefit and value.

In the area of prescription drug products, our work is primarily concentrated on cardiology and women’s healthcare, and on specialty therapeutics in the areas of oncology, hematology and ophthalmology.

In the area of mainly non-prescription medicines, we market products in segments including dermatology, pain relief, digestive health, allergy, cough and cold and cardiovascular prevention.

We collaborate with various partners around the world in programs and initiatives to support people to be able to share in medical progress, regardless of their income or where they live.

COLLABORATIONS

SHOWING 5 of 12 COLLABORATIONS

See All

Access Accelerated Initiative

Tackling the growing burden of non-communicable diseases in low and middle-income countries and supporting...

Access Accelerated, Almirall, Astellas Pharma Inc, Bayer AG, Bristol-Myers Squibb, Celgene, Chiesi Farmaceutici, Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Eli Lilly and Company, F. Hoffmann – La Roche Ltd., International Federation of Pharmaceutical Manufacturers & Associations, Johnson & Johnson, Menarini Group, Merck, MSD, Novartis, Pfizer Inc, Sanofi, Servier, Shionogi & Co., Ltd., Sumitomo Dainippon, Takeda Pharmaceutical Company Limited, UCB

SHOWING 5 of 12 COLLABORATIONS

See All